Use of serum CA-125 in monitoring patients with uterine sarcoma: A preliminary report
β Scribed by Bruce Patsner; William J. Mann
- Publisher
- John Wiley and Sons
- Year
- 1988
- Tongue
- English
- Weight
- 363 KB
- Volume
- 62
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## BACKGROUND. Prediction of peritoneal dissemination is very difficult using current diagnostic tools such as computed tomography, ultrasonography, or various tumor markers. The predictive value of serum CA 125 levels for peritoneal metastasis from gastric carcinoma was studied. ## METHODS. Th
W e read with interest the article published in Cancer earlier this year regarding the elevation of CA 125 in patients with non-Hodgkin's lymphoma and its normalization with clinical response. 1 Earlier a case report had also emerged about elevation of CA 125 in a patient within tuberculous peritoni
## Abstract ## BACKGROUND A prospective study was undertaken within the Gynecologic Oncology Group to determine whether serum levels of soluble tumor necrosis factor receptors I (sTNFRβI) and II (sTNFRβII), alone or in combination with CA 125, were associated with clinicopathologic characteristics
## Abstract ## Purpose: To quantify the accumulation of superparamagnetic iron oxide (SPIO) in patients with and without liver cirrhosis using T2 and T2\* mapping. ## Materials and Methods: We enrolled 10 patients without liver cirrhosis and 30 patients with liver cirrhosis (ChildβPugh class A,